The roughly twofold increased risk of AKI progressing to dialysis and nonresolving AKI we observed in non-DNMT3A-CHIP clones was similar in magnitude to that observed for CHIP and cardiovascular disease. This evidence concerns the gene DNMT3A and cardiovascular disorder.